The global downstream processing market size is expected to reach USD 94.79 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.84% from 2023 to 2030.  The capacity requirements during the development of biologic drugs have changed over the past few years, wherein the demand for manufacturing high-volume...

The global downstream processing market was valued at approximately USD 30.96 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 14.84% from 2023 to 2030. This growth is largely driven by the increased use of downstream processing techniques, particularly in the context of biopharmaceuticals and vaccine development. The COVID-19 pandemic significantly...

In today’s fast-paced medical world, data isn’t just numbers—it’s the heartbeat of innovation. Welcome to the age of Healthcare Analytics, where advanced data tools are reshaping the way we diagnose, treat, and even predict illnesses. Whether it’s hospitals optimizing patient outcomes or pharmaceutical companies speeding up drug discovery, healthcare analytics is...

In a world racing toward biologics, vaccines, and gene therapies, there's a silent powerhouse behind every scientific breakthrough: downstream processing. Often overlooked outside the biotech and pharma circles, this critical step in biomanufacturing is now taking center stage. The Downstream Processing Market is witnessing explosive growth, and it’s not slowing down anytime soon. But...